The 2nd wave is retreating. However, Kerala and to some Maharashtra are growing again as are the North East States. Meanwhile vaccination is averaging only 4 Mn doses/day. What are the possibilities for a 3rd wave? Read the presentation to see the latest position.
This presentation focuses on the 2nd wave in India. What may have caused it and by when will it abate. There are no definite answers at this stage but directions are laid out.
Deaths/day reached 1013 on 9th August and have declined thereafter with some fluctuations.
Infections/day reached 67,066 on 12th August and have declined thereafter with some fluctuations.
Active Infections reached 677,059 on 15th August and have declined thereafter.
On 9th August, cumulative deaths were 44,466 (32 deaths/Mn)
There are several caveats and possibilities still left as we will discuss further.
The co-relative model presented on 24.05.20 has been reasonably successful in predicting the date for first decline in deaths/day to start. Decline commenced on 15.09.20
The decline has been faster than anticipated. After a plateau in November and early December a declining trend is visible currently
North India’s spike after Diwali has come under control. As of now all states are stable/declining
In the next 30 days we may expect Deaths/Day to slowly decline further
71 cases of the new UK variant have been observed in India – no indications of local spread as of now. Genome has been mapped in UK and India. Implications for vaccine effectiveness awaited.
Vaccination logistics and process seem comprehensive and well thought through
Vaccination should start within a week or ten days
This document provides a summary and projection of Covid-19 data in India as of June 6, 2020. Key points include:
- Testing has increased to over 120,000 per day with a stabilizing positive rate of 7%
- New infections per day are over 10,000 but the doubling rate has slowed to 17 days
- Deaths are close to 300 per day with signs of slowing growth in major hotspots
- A projection model estimates cumulative deaths may reach 13,000-28,000 by mid-July if the current growth rate continues to decline.
Deaths/day are slowing down gradually. The trend is visible in most hotspots and at the All India level.
On June 16th, there was a massive spike in deaths (2004) caused by backlog data that was added for Maharashtra and Delhi. This distorted the trend, but subsequent days have shown a decline
Highlights
Cases and deaths continue to slowly decline. However there are some signs that cases are picking up again in some geographies
In the next 30 days we may expect Deaths/Day to slowly decline further
Key risk is of a second wave (possible but unlikely) caused either by a the existing variant or possibly a new one. Vaccination is too slow to provide herd immunity in the near future. India will have to rely on social distancing, masking etc for the foreseeable future
This presentation focuses on the 2nd wave in India. What may have caused it and by when will it abate. There are no definite answers at this stage but directions are laid out.
Deaths/day reached 1013 on 9th August and have declined thereafter with some fluctuations.
Infections/day reached 67,066 on 12th August and have declined thereafter with some fluctuations.
Active Infections reached 677,059 on 15th August and have declined thereafter.
On 9th August, cumulative deaths were 44,466 (32 deaths/Mn)
There are several caveats and possibilities still left as we will discuss further.
The co-relative model presented on 24.05.20 has been reasonably successful in predicting the date for first decline in deaths/day to start. Decline commenced on 15.09.20
The decline has been faster than anticipated. After a plateau in November and early December a declining trend is visible currently
North India’s spike after Diwali has come under control. As of now all states are stable/declining
In the next 30 days we may expect Deaths/Day to slowly decline further
71 cases of the new UK variant have been observed in India – no indications of local spread as of now. Genome has been mapped in UK and India. Implications for vaccine effectiveness awaited.
Vaccination logistics and process seem comprehensive and well thought through
Vaccination should start within a week or ten days
This document provides a summary and projection of Covid-19 data in India as of June 6, 2020. Key points include:
- Testing has increased to over 120,000 per day with a stabilizing positive rate of 7%
- New infections per day are over 10,000 but the doubling rate has slowed to 17 days
- Deaths are close to 300 per day with signs of slowing growth in major hotspots
- A projection model estimates cumulative deaths may reach 13,000-28,000 by mid-July if the current growth rate continues to decline.
Deaths/day are slowing down gradually. The trend is visible in most hotspots and at the All India level.
On June 16th, there was a massive spike in deaths (2004) caused by backlog data that was added for Maharashtra and Delhi. This distorted the trend, but subsequent days have shown a decline
Highlights
Cases and deaths continue to slowly decline. However there are some signs that cases are picking up again in some geographies
In the next 30 days we may expect Deaths/Day to slowly decline further
Key risk is of a second wave (possible but unlikely) caused either by a the existing variant or possibly a new one. Vaccination is too slow to provide herd immunity in the near future. India will have to rely on social distancing, masking etc for the foreseeable future
There has been a huge change between my last presentation on 14.02.21 and now. The second wave has India (and especially Maharashtra) suddenly and hard.
What are the contours of the second wave? How bad will it be and when will it start abating?
This presentation seeks to explore the above areas.
The last week has seen a spurt in deaths/day. This has been led by Maharashtra (minus Mumbai), Karnataka and other Southern States. UP, Bihar and West Bengal are growing fairly fast on a small base.
Delhi/Haryana/Gujarat are coming under control.
Mathematical projections have been impacted by the spurt in deaths. At the moment, we appear to be still growing. No clear decline is visible as yet.
• The highest point for Deaths/Day was 1281 on 15th September. This peak has
held till now (67 days)
• Deaths/Day have crossed 1000 on only 1 day after 3rd October. Declining trend
had set in followed by a plateau and a slow decline post the Diwali spike
• New/Active cases have also peaked and were declining.
• The highest no of cases was on 16th September at 97,856. That peak has held till now.
• Active Cases peaked at 10,17,718 on 17th September
• Both New and Active cases are plateauing/declining now
• Likely trend in Deaths/Day for the next 30 days is a plateau/slow decline
Deaths/Day have been fluctuating between 1000 – 1200 since 13th August
The highest point for Deaths/Day was 1283 on 15th September. This peak has held till now (20 days)
Almost all states are showing stable/declining trends in Deaths/Day
New/Active cases have also peaked and are declining.
The highest no of cases was on 16th September at 97,856. That peak has held till now.
Active Cases peaked at 10,17,718 on 17th September
The highest point for Deaths/Day was 1283 on 15th September. This peak has held till now (35 days)
Deaths/Day have crossed 1000 on only 1 day after 3rd October. Distinct declining trend has set in.
Almost all states are showing stable/declining trends in Deaths/Day
New/Active cases have also peaked and are declining.
The highest no of cases was on 16th September at 97,856. That peak has held till now.
Active Cases peaked at 10,17,718 on 17th September
R0 value has dropped to 0.93 on 25th September
North India’s spike after Diwali has come under control. As of now all states are declining
In the next 30 days we may expect Deaths/Day to slowly decline further
150 cases of the new UK variant have been observed in India – no indications of local spread as of now. Genome has been mapped in UK and India. Implications for vaccine effectiveness awaited
Sero positive study in Delhi has come up with 50% positive in Delhi. Significant jump in a few months. This may hasten the progress to herd immunity. Results awaited
Vaccination has got off to a slow start with numbers picking up gradually. India cumulative upto 24.01.21 is 1,615,504 jabs in 9 days. Average of 179,500 per day. USA 20.54 Mn from 14th Dec (42 days) = 489,047 per day
Key risk is of a second wave (possible but unlikely) caused either by a the existing variant or possibly a new one. Vaccination is too slow to provide herd immunity in the near future. India will have to rely on social distancing, masking etc for the foreseeable future
Predicting coronavirus cases and questions need answeringJames Orr
Another weekend, and another attempt to make sense out of the Coronavirus Case data from states in the United States. Overall, cases per day remain flat (on plateau) with no decline in data. However, other indications suggest increasing irrelevant to use new cases per day for social policy decisions. Indication that new hospitalizations per day might be a better measure.
This document provides a summary and analysis of Covid-19 data in India as of May 24, 2021. It notes that testing has not kept pace with the second wave and positivity rates remain high. While cases nationally have peaked and are declining, deaths have yet to do so in many states. The consistency seen in how quickly cases increased across states and have since declined suggests the dominant B.1.617.2 variant spreads very rapidly. Vaccination rates need to increase substantially to 2.8 million doses per day as targeted for May. The document analyzes vaccination needs by population group and notes current rates are only around 1.5 million per day.
The Philippines now has over 2.75 million confirmed COVID-19 cases after reporting over 5,000 new cases for two straight days. The death toll stands at over 41,500 with over 63,000 active cases. WHO Philippines expressed concern over the low vaccination rate of only 25% for senior citizens, leaving over 6.4 million elderly at high risk. They call for accelerated vaccination efforts for senior citizens given the threat posed by the Delta variant.
- Scientists in South Africa identified a new COVID-19 variant called Omicron which has been designated a variant of concern by the WHO.
- Early identification of Omicron is due to South Africa's genomic surveillance capabilities which have helped monitor the virus.
- Some key things known about Omicron so far include that it has many more mutations than prior variants, current tests can detect it, and it is spreading rapidly in South Africa. However, more data is still needed on transmission risk, reinfection risk, severity of disease, and vaccine effectiveness.
- COVID cases in South Africa have risen sharply recently, likely signaling the start of a fourth wave, and daily case numbers have more than tripled in the
This document provides an analysis of Covid-19 data in India through December 21, 2020 and projects future trends. Key highlights include:
- Daily deaths peaked at 1281 on September 15 and have been declining since, plateauing around 500 in November and trending downward recently.
- New and active cases have also peaked and are declining, with the highest new cases on September 16 of 97,856.
- A projection model based on data from other countries estimates India's daily deaths may slowly decline over the next 30 days.
- While a second wave is possible, it is considered unlikely for India as a whole based on trends in most other countries of declines after initial peaks.
There are two kinds of fools: those who can't change their opinions and those who won't.
- Josh Billings
Never tell a fool that he is a fool. All you'll have is an angry fool.
- The Talmud
Incorporate the visual brilliance of COVID 19 Template PowerPoint Presentation Slides to deliver a gripping presentation. Using the coronavirus PPT theme, you can display global epicenters of this pandemic on a world map diagram. With the help of this corona PowerPoint slideshow, you can spread awareness by communicating symptoms of the disease. Demonstrate the healthcare system capacity and the number of cases using the line graph given in the COVID 19 PPT template. The concise dashboard diagrams included in this 2019-nCoV disease PowerPoint presentation are appropriate to showcase key statistics of the pandemic. Novel coronavirus pneumonia PPT slideshow helps you to highlight the major pandemics of the modern era like the 1700s smallpox outbreak. Elucidate country-wise stats related to the disease using the dashboard layout in this severe pneumonia with novel pathogens PowerPoint theme. So, download this COVID-19 PPT presentation to outline the affected areas, precautionary measures, and other fundamentals. https://bit.ly/3yA9QwF
The document summarizes the potential economic impacts of the Zika virus in Latin America and the Caribbean. It notes that the World Bank estimates the potential costs could reach $3.5 billion or 0.06% of annual GDP across the region. Both short-term impacts like declines in tourism and longer-term impacts from delayed child-bearing are discussed. Cost-effectiveness of prevention options like vaccine development and vector control are also examined. Developing a Zika vaccine faces challenges around sporadic outbreaks. Vector control of Aedes aegypti could help reduce dengue and potentially lower Zika severity, but may paradoxically increase future Zika infection rates during pregnancy.
A Fundação Fernando Henrique Cardoso (FFHC) e o Centro Brasileiro de Relações Internacionais (CEBRI) convidam para o webinar:
China and the New Coronavirus: challenges of an interconnected world
Neste evento, o economista Arthur Kroeber, diretor da Gavegal Dragonomics, empresa de consultoria global com foco na economia chinesa, apresentará sua visão sobre o impacto da pandemia do Covid - 19 na China e na economia mundial. Apoiado em ampla base de dados e reconhecida capacidade analítica, traçará cenários para o futuro imediato e de médio prazo, considerando as dimensões do desafio e as respostas dadas até aqui pelo governo da China, dos Estados Unidos e da Europa.
PALESTRANTE
ARTHUR KROEBER
Sócio Fundador e Chefe de Pesquisa da Gavekal, foi co-fundador do serviço de pesquisa Dragonomics, com foco na China, em 2002, em Pequim, e é o editor-chefe do China Economic Quarterly. Desde a fusão da Dragonomics em 2011 com a Gavekal Research, ele foi chefe de pesquisa da operação combinada. Antes de fundar a Dragonomics, ele foi de 1987 a 2002 um jornalista especializado em assuntos econômicos asiáticos, e reportou da China, Índia, Paquistão e outros países asiáticos. Ele publicou amplamente em jornais, revistas e periódicos acadêmicos e é membro do Brookings-Tsinghua Center em Pequim.
This presentation includes facts and figures assembled by Gen Re for the U.S. Life insurance industry. The information has been assembled in honor of the Life Foundation's Life Insurance Awareness Month campaign (September 2014).
01 Malope Monitoring The Social And Other Impacts Of Hiv Malope, N.SNicholas Jacobs
The document summarizes indicators for monitoring the social and demographic impact of HIV/AIDS in South Africa. It discusses 3 key indicators: 1) death rate among ages 15-49, which has increased due to AIDS-related deaths; 2) under-5 and infant mortality rates, both of which declined from 1990 to 2009 due to improved health interventions but remain elevated due to HIV; and 3) cause-specific mortality rates, where HIV/AIDS is now the leading cause of death in South Africa. The document reviews trends in these indicators and concludes that HIV/AIDS has had a serious impact on mortality and demographic changes in South Africa.
The document describes projections for COVID-19 infections in India using an agent-based model of the Indian population called IndiaSIM. It presents three scenarios - high, medium, and low - based on different assumptions for factors like compliance with lockdowns and virus characteristics. State-level estimates are driven by seeding dates, major metro areas, flight connections, and demographics. The model predicts total infections, hospitalizations, and outcomes for some states through July 2020 under the three scenarios.
Dr Jennifer Njenga presented a workshop for LCCMedia Foundation on Vaccines and You. This workshop is the first of three workshops that Dr. Jennifer will deliver for the Foundation.
She covered how the virus spreads, how to prevent and the the efficacy of the vaccines.
Several hundred German doctors and scientists have formed a committee to investigate the response to the coronavirus pandemic. A representative of the committee stated "we have a lot of evidence that it [the story of COVID-19] is a fake story all over the world," referring to evidence that COVID-19 is no more dangerous than seasonal flu. The article discusses experts who have been censored for questioning government narratives around COVID-19. It argues that there is conflicting information and censorship of alternatives, and asks whether governments are manipulating perception during the pandemic.
This document summarizes Covid-19 data in India as of June 7, 2021 and projects potential scenarios for a third wave. Key points include:
- Testing rates have declined while positivity rates remain above 5%, and cumulative CFR has risen indicating the second wave was more lethal.
- Cases peaked in early May but are declining, though the rate of decline is slowing. Active cases and deaths are also declining.
- States peaked within 3-4 weeks of each other, suggesting the dominant Delta variant spreads rapidly. Declines are also consistent across states.
- The consistency of rises and falls implies human interventions have low impact once a wave starts, and virus/variant traits may drive peaks and trough
The 11th Update of Covid Stats in India was presented by Debu Bhatnagar on 3.11.20. Neeraj Chandra presented a model that seeks to understand the shapes of the Covid curves for different countries.
There has been a huge change between my last presentation on 14.02.21 and now. The second wave has India (and especially Maharashtra) suddenly and hard.
What are the contours of the second wave? How bad will it be and when will it start abating?
This presentation seeks to explore the above areas.
The last week has seen a spurt in deaths/day. This has been led by Maharashtra (minus Mumbai), Karnataka and other Southern States. UP, Bihar and West Bengal are growing fairly fast on a small base.
Delhi/Haryana/Gujarat are coming under control.
Mathematical projections have been impacted by the spurt in deaths. At the moment, we appear to be still growing. No clear decline is visible as yet.
• The highest point for Deaths/Day was 1281 on 15th September. This peak has
held till now (67 days)
• Deaths/Day have crossed 1000 on only 1 day after 3rd October. Declining trend
had set in followed by a plateau and a slow decline post the Diwali spike
• New/Active cases have also peaked and were declining.
• The highest no of cases was on 16th September at 97,856. That peak has held till now.
• Active Cases peaked at 10,17,718 on 17th September
• Both New and Active cases are plateauing/declining now
• Likely trend in Deaths/Day for the next 30 days is a plateau/slow decline
Deaths/Day have been fluctuating between 1000 – 1200 since 13th August
The highest point for Deaths/Day was 1283 on 15th September. This peak has held till now (20 days)
Almost all states are showing stable/declining trends in Deaths/Day
New/Active cases have also peaked and are declining.
The highest no of cases was on 16th September at 97,856. That peak has held till now.
Active Cases peaked at 10,17,718 on 17th September
The highest point for Deaths/Day was 1283 on 15th September. This peak has held till now (35 days)
Deaths/Day have crossed 1000 on only 1 day after 3rd October. Distinct declining trend has set in.
Almost all states are showing stable/declining trends in Deaths/Day
New/Active cases have also peaked and are declining.
The highest no of cases was on 16th September at 97,856. That peak has held till now.
Active Cases peaked at 10,17,718 on 17th September
R0 value has dropped to 0.93 on 25th September
North India’s spike after Diwali has come under control. As of now all states are declining
In the next 30 days we may expect Deaths/Day to slowly decline further
150 cases of the new UK variant have been observed in India – no indications of local spread as of now. Genome has been mapped in UK and India. Implications for vaccine effectiveness awaited
Sero positive study in Delhi has come up with 50% positive in Delhi. Significant jump in a few months. This may hasten the progress to herd immunity. Results awaited
Vaccination has got off to a slow start with numbers picking up gradually. India cumulative upto 24.01.21 is 1,615,504 jabs in 9 days. Average of 179,500 per day. USA 20.54 Mn from 14th Dec (42 days) = 489,047 per day
Key risk is of a second wave (possible but unlikely) caused either by a the existing variant or possibly a new one. Vaccination is too slow to provide herd immunity in the near future. India will have to rely on social distancing, masking etc for the foreseeable future
Predicting coronavirus cases and questions need answeringJames Orr
Another weekend, and another attempt to make sense out of the Coronavirus Case data from states in the United States. Overall, cases per day remain flat (on plateau) with no decline in data. However, other indications suggest increasing irrelevant to use new cases per day for social policy decisions. Indication that new hospitalizations per day might be a better measure.
This document provides a summary and analysis of Covid-19 data in India as of May 24, 2021. It notes that testing has not kept pace with the second wave and positivity rates remain high. While cases nationally have peaked and are declining, deaths have yet to do so in many states. The consistency seen in how quickly cases increased across states and have since declined suggests the dominant B.1.617.2 variant spreads very rapidly. Vaccination rates need to increase substantially to 2.8 million doses per day as targeted for May. The document analyzes vaccination needs by population group and notes current rates are only around 1.5 million per day.
The Philippines now has over 2.75 million confirmed COVID-19 cases after reporting over 5,000 new cases for two straight days. The death toll stands at over 41,500 with over 63,000 active cases. WHO Philippines expressed concern over the low vaccination rate of only 25% for senior citizens, leaving over 6.4 million elderly at high risk. They call for accelerated vaccination efforts for senior citizens given the threat posed by the Delta variant.
- Scientists in South Africa identified a new COVID-19 variant called Omicron which has been designated a variant of concern by the WHO.
- Early identification of Omicron is due to South Africa's genomic surveillance capabilities which have helped monitor the virus.
- Some key things known about Omicron so far include that it has many more mutations than prior variants, current tests can detect it, and it is spreading rapidly in South Africa. However, more data is still needed on transmission risk, reinfection risk, severity of disease, and vaccine effectiveness.
- COVID cases in South Africa have risen sharply recently, likely signaling the start of a fourth wave, and daily case numbers have more than tripled in the
This document provides an analysis of Covid-19 data in India through December 21, 2020 and projects future trends. Key highlights include:
- Daily deaths peaked at 1281 on September 15 and have been declining since, plateauing around 500 in November and trending downward recently.
- New and active cases have also peaked and are declining, with the highest new cases on September 16 of 97,856.
- A projection model based on data from other countries estimates India's daily deaths may slowly decline over the next 30 days.
- While a second wave is possible, it is considered unlikely for India as a whole based on trends in most other countries of declines after initial peaks.
There are two kinds of fools: those who can't change their opinions and those who won't.
- Josh Billings
Never tell a fool that he is a fool. All you'll have is an angry fool.
- The Talmud
Incorporate the visual brilliance of COVID 19 Template PowerPoint Presentation Slides to deliver a gripping presentation. Using the coronavirus PPT theme, you can display global epicenters of this pandemic on a world map diagram. With the help of this corona PowerPoint slideshow, you can spread awareness by communicating symptoms of the disease. Demonstrate the healthcare system capacity and the number of cases using the line graph given in the COVID 19 PPT template. The concise dashboard diagrams included in this 2019-nCoV disease PowerPoint presentation are appropriate to showcase key statistics of the pandemic. Novel coronavirus pneumonia PPT slideshow helps you to highlight the major pandemics of the modern era like the 1700s smallpox outbreak. Elucidate country-wise stats related to the disease using the dashboard layout in this severe pneumonia with novel pathogens PowerPoint theme. So, download this COVID-19 PPT presentation to outline the affected areas, precautionary measures, and other fundamentals. https://bit.ly/3yA9QwF
The document summarizes the potential economic impacts of the Zika virus in Latin America and the Caribbean. It notes that the World Bank estimates the potential costs could reach $3.5 billion or 0.06% of annual GDP across the region. Both short-term impacts like declines in tourism and longer-term impacts from delayed child-bearing are discussed. Cost-effectiveness of prevention options like vaccine development and vector control are also examined. Developing a Zika vaccine faces challenges around sporadic outbreaks. Vector control of Aedes aegypti could help reduce dengue and potentially lower Zika severity, but may paradoxically increase future Zika infection rates during pregnancy.
A Fundação Fernando Henrique Cardoso (FFHC) e o Centro Brasileiro de Relações Internacionais (CEBRI) convidam para o webinar:
China and the New Coronavirus: challenges of an interconnected world
Neste evento, o economista Arthur Kroeber, diretor da Gavegal Dragonomics, empresa de consultoria global com foco na economia chinesa, apresentará sua visão sobre o impacto da pandemia do Covid - 19 na China e na economia mundial. Apoiado em ampla base de dados e reconhecida capacidade analítica, traçará cenários para o futuro imediato e de médio prazo, considerando as dimensões do desafio e as respostas dadas até aqui pelo governo da China, dos Estados Unidos e da Europa.
PALESTRANTE
ARTHUR KROEBER
Sócio Fundador e Chefe de Pesquisa da Gavekal, foi co-fundador do serviço de pesquisa Dragonomics, com foco na China, em 2002, em Pequim, e é o editor-chefe do China Economic Quarterly. Desde a fusão da Dragonomics em 2011 com a Gavekal Research, ele foi chefe de pesquisa da operação combinada. Antes de fundar a Dragonomics, ele foi de 1987 a 2002 um jornalista especializado em assuntos econômicos asiáticos, e reportou da China, Índia, Paquistão e outros países asiáticos. Ele publicou amplamente em jornais, revistas e periódicos acadêmicos e é membro do Brookings-Tsinghua Center em Pequim.
This presentation includes facts and figures assembled by Gen Re for the U.S. Life insurance industry. The information has been assembled in honor of the Life Foundation's Life Insurance Awareness Month campaign (September 2014).
01 Malope Monitoring The Social And Other Impacts Of Hiv Malope, N.SNicholas Jacobs
The document summarizes indicators for monitoring the social and demographic impact of HIV/AIDS in South Africa. It discusses 3 key indicators: 1) death rate among ages 15-49, which has increased due to AIDS-related deaths; 2) under-5 and infant mortality rates, both of which declined from 1990 to 2009 due to improved health interventions but remain elevated due to HIV; and 3) cause-specific mortality rates, where HIV/AIDS is now the leading cause of death in South Africa. The document reviews trends in these indicators and concludes that HIV/AIDS has had a serious impact on mortality and demographic changes in South Africa.
The document describes projections for COVID-19 infections in India using an agent-based model of the Indian population called IndiaSIM. It presents three scenarios - high, medium, and low - based on different assumptions for factors like compliance with lockdowns and virus characteristics. State-level estimates are driven by seeding dates, major metro areas, flight connections, and demographics. The model predicts total infections, hospitalizations, and outcomes for some states through July 2020 under the three scenarios.
Dr Jennifer Njenga presented a workshop for LCCMedia Foundation on Vaccines and You. This workshop is the first of three workshops that Dr. Jennifer will deliver for the Foundation.
She covered how the virus spreads, how to prevent and the the efficacy of the vaccines.
Several hundred German doctors and scientists have formed a committee to investigate the response to the coronavirus pandemic. A representative of the committee stated "we have a lot of evidence that it [the story of COVID-19] is a fake story all over the world," referring to evidence that COVID-19 is no more dangerous than seasonal flu. The article discusses experts who have been censored for questioning government narratives around COVID-19. It argues that there is conflicting information and censorship of alternatives, and asks whether governments are manipulating perception during the pandemic.
This document summarizes Covid-19 data in India as of June 7, 2021 and projects potential scenarios for a third wave. Key points include:
- Testing rates have declined while positivity rates remain above 5%, and cumulative CFR has risen indicating the second wave was more lethal.
- Cases peaked in early May but are declining, though the rate of decline is slowing. Active cases and deaths are also declining.
- States peaked within 3-4 weeks of each other, suggesting the dominant Delta variant spreads rapidly. Declines are also consistent across states.
- The consistency of rises and falls implies human interventions have low impact once a wave starts, and virus/variant traits may drive peaks and trough
The 11th Update of Covid Stats in India was presented by Debu Bhatnagar on 3.11.20. Neeraj Chandra presented a model that seeks to understand the shapes of the Covid curves for different countries.
Deaths/day reached 1013 on 9th August and started declining. There was another peak on 18th August of 1099 which has held till now.
Plateauing is established. Sharp declines are yet to be seen.
Assuming the 18th August peak holds, the following predictions may follow:
A decline in the 7 DMA in the next 2 weeks by 10 – 30 deaths/day
Decline in daily deaths to 50% of peak level in November
The highest point for Deaths/Day was 1281 on 15th September. This peak has held till now (67 days)
Deaths/Day have crossed 1000 on only 1 day after 3rd October. Declining trend had set in but is now plateauing/trending upwards due to a spike in Delhi and North India.
New/Active cases have also peaked and were declining.
The highest no of cases was on 16th September at 97,856. That peak has held till now.
Active Cases peaked at 10,17,718 on 17th September
Both New and Active cases are plateauing/trending upwards now
Vaccine developments hold promise for India via Astra Zeneca and Novavax tie up with Serum Institute of India, Sputnik with Dr Reddy’s, J&J with Biological E and Bharat Biotech. All these vaccines are in Phase 3. Cadila in Phase 2 is also promising.
Kerala tackled the COVID-19 pandemic through its strong public health system and proactive measures. It implemented a three tier public health system and decentralized governance. When cases emerged in January, Kerala conducted aggressive testing, intensive contact tracing, and established quarantine facilities. The government issued clear guidelines, recruited additional health workers, and implemented social welfare measures. As a result, Kerala was able to flatten the curve with only a few new cases reported in May. However, the pandemic has negatively impacted Kerala's economy which relies on tourism and remittances. A new low-cost COVID-19 diagnostic test kit developed in Kerala could help scale up testing if approved.
Predictions of decline made on 1.09.20 have not held.
There has been a spurt in deaths in the key states of Maharashtra, Karnataka and Delhi that is still continuing.
Punjab and UP are especially worrying
Very recent trends are again showing stability/decline in deaths
Researchers at the Network Dynamics and Simulation Science Laboratory have been using a combination of modeling techniques to predict the spread of the Ebola outbreak.
Researchers at the Network Dynamics and Simulation Science Laboratory have been using a combination of modeling techniques to predict the spread of the Ebola outbreak.
This report looks at the health intervention data from MDS to assess the extent
of the impact that extensive screening and testing has had on the control of COVID-19 in
Pune. It analyses data on the screenings, suspected, and positive cases detected by MDS to
look at the effect of their targeted interventions. Within this, it specifically looks at the
effects of casting a wider testing net, early detection of cases, and the effect of this on the
deaths due to COVID.
CPC Report on The Impact of BJS' Mobile Dispensary SEVA during COVID-19.
Analysing the impact of a joint initiative of Pune Municipal Corporation, Bharatiya Jain Sanghatana and Force Motors in the fight against COVID-19 in Pune City.
Researchers at the Network Dynamics and Simulation Science Laboratory have been using a combination of modeling techniques to predict the spread of the Ebola outbreak.
Researchers at the Network Dynamics and Simulation Science Laboratory have been using a combination of modeling techniques to predict the spread of the Ebola outbreak.
Researchers at the Network Dynamics and Simulation Science Laboratory have been using a combination of modeling techniques to predict the spread of the Ebola outbreak.
Timeliness of Malaria Treatment in Children Under Five Years of Age in sub-Sa...MEASURE Evaluation
This study analyzed national survey data from 12 sub-Saharan African countries to assess the timeliness of malaria treatment for children under 5. It found that overall, 63% of children received prompt antimalarial treatment within 24 hours of fever onset. Maternal education level, household wealth, and country of residence were key predictors of timely treatment access. Children with higher-educated and wealthier mothers and those living in Mozambique, Zanzibar, Malawi, Rwanda, Senegal and Tanzania were most likely to receive prompt and effective malaria treatment.
We conduct this study to check the effect of COVID-19 on income of general public. We used questionnaire & face to face interviews to get results for this study & then applied different charts & percentage analysis to finalize this research. Sample size for this study was 620 but only 250 people respond it. Data was collected by sending questionnaires through WhatsApp & Facebook messenger & by taking face to face interviews from poor people and aged people because they don’t use social media mostly. Our respond rate was 40%. Study concluded that mostly owners are giving salaries to their employees and their income also fulfill their expenses, but this is opposite in case of poor people & daily wagers. Their daily expenses also effected due to this lockdown. Private workers are most effected persons in the lockdown.
Risk and Survival Analysis from COVID Outbreak DataVineet Kumar
This document summarizes the results of a study analyzing COVID-19 outbreak data from India to derive lessons. It used clustering analysis to group states based on active cases, finding Maharashtra as the worst affected and others like Kerala, Delhi, Uttar Pradesh, and West Bengal among the second worst. Survival analysis on patient data from Karnataka found the median recovery time was 8 days, with older patients (>60) having only 4 days and adults (18-60) having 33 days. It also found males had a median survival time 7 days less than females, and a Cox proportional hazards model showed males had a 1.26 times higher risk of decreased survival.
Researchers at the Network Dynamics and Simulation Science Laboratory have been using a combination of modeling techniques to predict the spread of the Ebola outbreak.
The document summarizes the findings of a phone survey conducted in January 2021 on the impact of COVID-19 on rural communities in Cross River and Kaduna states in Nigeria. Key findings include:
- Around 80% of households reported loss of income due to COVID-19 across both states. Coping strategies included using savings, selling assets, borrowing money, and receiving government/NGO transfers.
- Mobility was severely constrained, with around three-quarters of respondents reporting less mobility than before COVID-19. Around 70% of respondents experienced food insecurity.
- Care burdens increased for both men and women. Male respondents reported spending more time on care than women acknowledged. International migration decreased while internal migration increased
This document summarizes the results of a phone survey conducted in Kenya that assessed the impact of COVID-19 on rural households. Some key findings:
- Confirmed COVID-19 cases in Kenya had risen to over 88,000 by the survey date, with a 1.7% fatality rate.
- Most respondents continued to experience income losses due to the pandemic, with over 80% of women and 64% of men reporting losses. Common coping mechanisms like using savings and selling assets had declined significantly.
- Mobility remained restricted for most (89%), primarily to buy food or attend religious functions. Food insecurity was widespread, with 70% unable to afford nutritious foods.
Similar to Covid 19 stats in india update 23 13.07.21 (20)
Learn about YFactor's Advisory Services and Team Members. We are over 8 years old and comprise of 12 Directors and Senior Advisors. We are based in India and are focused on Consumer Facing Businesses. Our range of Advisory Services include India Entry, Strategy, Supply Chain, Branding, Human Resources and Distribution. Mail us at contact@yfactor.in
This document provides an overview of YFactor, a business advisory firm for FMCG companies in India. It then discusses India's demographics and FMCG market, highlighting the large and diverse population across urban and rural areas. The physical distribution system for FMCG goods in India is also outlined, involving movement from factories to stockists to urban and rural retailers. A case study is then presented on distribution planning, order taking, monitoring and control for an upper mass personal care company operating in India. Key decisions around town coverage, outlet coverage and sales force deployment are discussed. The use of a handheld system for digital order taking, reporting and sales force management is also summarized.
Fact, fiction and speculation have a habit of blending together when one looks at ancient India. In this article I have put forward my point of view – it is not accepted historical dogma and neither is it original. It is speculative and interesting as it has many facets. Enjoy the read!
The document discusses opportunities in the FMCG sector in India. Some key points:
1. The Indian FMCG market is large at $24 billion but has room for growth as per capita consumption is lower than other countries. North India is a vibrant market driven by tax concessions, income growth, and innovative local companies.
2. Modern trade is growing rapidly but organized retail penetration is still low at 4.8% compared to other countries. FMCG companies can benefit from modern trade through de-intermediation, economies of scale, and better measurement.
3. Rural and urban markets both offer opportunities but have different characteristics. Rural prosperity and government programs are driving rural growth while urbanization and lifestyle changes spur
This document discusses India's complex indirect taxation system and the proposed introduction of a Goods and Services Tax (GST). It notes that India currently has the highest percentage of indirect taxes compared to other countries. The document outlines the evolution of India's indirect tax system over time, including the introduction of excise duties, sales taxes, and value-added taxes at different government levels. It argues that while reforms have benefited consumers and companies, a unified GST is still needed to further simplify the system. The proposed GST model and potential impacts on the FMCG industry are also summarized, including reduced compliance costs and elimination of some cascading taxes.
The document summarizes the changing landscape of the FMCG industry in India. It notes that while Hindustan Unilever remains the largest player, their dominance is declining as local Indian companies like ITC and Dabur grow rapidly. Emerging Indian FMCG companies under Rs. 500 crore in revenue are experiencing especially fast growth in recent years by focusing on local Indian tastes and habits, underserved categories, and areas vacated by multinational corporations. Key factors driving the success of these local players include an understanding of the local Indian market and preferences.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
low birth weight presentation. Low birth weight (LBW) infant is defined as the one whose birth weight is less than 2500g irrespective of their gestational age. Premature birth and low birth weight(LBW) is still a serious problem in newborn. Causing high morbidity and mortality rate worldwide. The nursing care provide to low birth weight babies is crucial in promoting their overall health and development. Through careful assessment, diagnosis,, planning, and evaluation plays a vital role in ensuring these vulnerable infants receive the specialize care they need. In India every third of the infant weight less than 2500g.
Birth period, socioeconomical status, nutritional and intrauterine environment are the factors influencing low birth weight
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfRahul Sen
Time-lapse embryo monitoring is an advanced imaging technique used in IVF to continuously observe embryo development. It captures high-resolution images at regular intervals, allowing embryologists to select the most viable embryos for transfer based on detailed growth patterns. This technology enhances embryo selection, potentially increasing pregnancy success rates.
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
Summer is a time for fun in the sun, but the heat and humidity can also wreak havoc on your skin. From itchy rashes to unwanted pigmentation, several skin conditions become more prevalent during these warmer months.
Know the difference between Endodontics and Orthodontics.Gokuldas Hospital
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...AyushGadhvi1
learning occurs when a stimulus (unconditioned stimulus) eliciting a response (unconditioned response) • is paired with another stimulus (conditioned stimulus)
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
10 Benefits an EPCR Software should Bring to EMS Organizations Traumasoft LLC
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
1. Covid 19 Stats in India –
Update 23
Review of key data and presentation of a projection model
Data updated till 12.07.21
Data Sources: https://www.covid19india.org/; https://www.worldometers.info/;
https://censusindia.gov.in/2011-prov-results/paper2/data_files/india/paper2_1.pdf
https://ig.ft.com/coronavirus-
chart/?areas=eur&areas=usa&areas=bra&areas=gbr&areasRegional=usny&areasRegional=usca&areasRegional=usfl&area
sRegional=ustx&byDate=0&cumulative=0&logScale=1&perMillion=0&values=deaths
https://ourworldindata.org/covid-vaccinations
https://www.mygov.in/aarogya-Setu-app/
2. Agenda
• Presentation of key data for All India
• Review of cases and deaths in states
• Kerala – The Canary in the Coal Mine
• Vaccination
• 3rd Wave predictions
• Discussion
3. Data Integrity
• India data on deaths is being strongly questioned by researchers both in
India and abroad. Anywhere between 2 – 4 times the official death rate is
being talked about as the real figure
• Cases are anyway ‘discovered cases’ and it is well known that the real
figure is multiple times
• Approach
• We will look at surrogate variables to get a directional indication (TPR and Daily
Growth in Active Cases are two such)
• We will also use the official numbers for modelling and look for correlation with the
surrogate variables
5. • Testing was not been able to keep pace with the
pandemic after the second wave started
• Positivity rates had crossed 20% (the peak in
September was 15%) in the 2nd wave. With the ramp
up of testing, TPR went below 5% after the first week
of June.
• TPR reached a peak of 24.85% on 9th May. It declined
thereafter but testing has been coming down in July.
This is leading to an increase in TPR in the last few
days.
• Kerala (10.5%) has high TPR along with the North
Eastern States. Maharashtra TPR has dropped below
5% indicating that the pandemic is coming under
control.
6. • Cumulative CFR is trending upwards. This is a
disturbing trend indicating that fatalities in the 2nd
wave are higher
• This is clearly visible when you see the 7DMA CFR.
The adjustment of previous period fatalities
repeatedly by Maharashtra and now by MP have
rendered the fatality numbers infructuous for any
meaningful analysis
7. • New infections reached their lowest point on 11.02.21 at 10,983
7DMA
• Cases had galloped after that and the previous peak was
surpassed on 4.04.21
• The highest number has been 414,280 on 6 May. The highest
level on a 7DMA basis was 392,330 on 8th May. The declining
trend in cases is now well established. When coupled with a
decreasing TPR this is a more robust figure. Daily cases have
dipped below 50,000 on 27.06.21 for the first time after the
decline commenced. On 12.07.21 the 7DMA is 40,828
• The pace of decline has slowed down. However it has still not
turned upwards. We will analyse Kerala, the most problematic
state later
8. • Active Infections have peaked. From 22nd April, the rate
of growth has been slowing.
• On 10th May for the first time in the second wave, Active
Infections declined by 30,499. Thereafter, the declining
trend has got established
• Daily Growth in Active Infections is a reasonable lead
indicator of what direction the wave is taking
• The load on the healthcare system is also coming down
• However, the rate of decline in Active Infections is
slowing down. This is another indicator that a plateau
may be approaching
9. • Deaths had reached a plateau from around the
10th of May. However, the numbers have been
distorted by Previous Period Adjustments carried
out by Maharashtra on several days and now by
MP.
• For this presentation I have shown the raw
numbers without adjustment
• The 7DMA is showing a peaking on 23rd May. The
30 DMA has peaked on 27th May
• The salient point is that deaths have continued to
grow after cases peaked on 8th May on a 7DMA
basis. This may indicate that serious cases are
taking more time to resolve. Complications such
as Mucormycosis also came up.
• The declining trend is now clearly established.
Hopefully further PPAs will not happen.
• Clearly, fatalities are not a reliable number for
forecasting at this point
11. • Kerala (discussed separately) and Maharashtra (plateauing) are the two major problem states
• North East is also rising
• All others have declined
13. • The 2nd wave in Kerala peaked at the same time as most of
the other states on 12.05.21 at 38,143 cases 7DMA.
• The decline afterwards was also in line with the rest of the
country though a bit slower.
• The lowest point reached was on 19.06.21 at 12,091 cases
7DMA.
• Since then the cases curve has been flattish with a little
growth. Deaths are clearly rising.
14. Rural Urban Total % Urban Cum Cases Cum Deaths Cases/Mn Deaths/Mn Tests % Cases to pop Tests/Mn
1 Ernakulam 10,47,296 22,32,564 32,79,860 68.1% 3,69,430 1,435 1,12,636 438 11.3%
2 Thrissur 10,20,537 20,89,790 31,10,327 67.2% 2,87,217 1,515 92,343 487 9.2%
3 Kozhikode 10,14,765 20,74,778 30,89,543 67.2% 3,23,524 1,436 1,04,716 465 10.5%
4 Kannur 8,82,745 16,42,892 25,25,637 65.0% 1,68,211 919 66,601 364 6.7%
5 Alappuzha 9,74,916 11,47,027 21,21,943 54.1% 2,06,729 1,047 97,424 493 9.7%
6 Thiruvananthapuram 15,28,030 17,79,254 33,07,284 53.8% 3,10,974 2,989 94,027 904 9.4%
7 Kollam 14,43,363 11,86,340 26,29,703 45.1% 2,42,834 1,008 92,343 383 9.2%
8 Malappuram 22,94,473 18,16,483 41,10,956 44.2% 3,53,295 1,126 85,940 274 8.6%
9 Kasargod 7,97,424 5,05,176 13,02,600 38.8% 92,325 277 70,877 213 7.1%
10 Kottayam 14,13,773 5,65,611 19,79,384 28.6% 2,03,473 592 1,02,796 299 10.3%
11 Palakkad 21,33,699 6,77,193 28,10,892 24.1% 2,19,711 1,282 78,164 456 7.8%
12 Pathanamthitta 10,64,076 1,31,461 11,95,537 11.0% 1,21,443 458 1,01,580 383 10.2%
13 Idukki 10,55,428 52,025 11,07,453 4.7% 85,748 162 77,428 146 7.7%
14 Wayanad 7,84,981 31,577 8,16,558 3.9% 68,202 243 83,524 298 8.4%
Kerala 1,74,55,506 1,59,32,171 3,33,87,677 47.7% 30,53,116 14,489 91,444 434 2,43,08,000 9.1% 7,28,053
Maharashtra 11,23,74,333 45.2% 61,49,264 1,25,528 54,721 1,117 4,38,00,139 5.5% 3,89,770
All India 1,21,05,69,573 31.2% 3,08,36,262 4,08,072 25,473 337 43,08,85,470 2.5% 3,55,936
• As expected, the correlation between Urbanisation and Covid impact is not there for Kerala
• Testing in Kerala is more than double of the national average.
• Discovered Cases per/mn in Kerala are very high – this is mostly due to higher testing but also that TPR (10.4%) is still high. Almost 10%
of the population (2011 census) has had Covid (discovered)
• Anecdotally, the identification of Covid deaths is better in Kerala. Hence, the recorded deaths/mn are higher than the national average
but if unrecorded deaths are taken into account the national figure would be far higher
15. • Thiruvananthapuram is the only district recording a continuing decline in cases
• Other districts on this slide are showing a flattening/slowly rising trend
16. • All these districts are showing a rising trend
17. Kerala Discussion
• As of now, no new VOC has been identified in Kerala
• Hence the rise in cases may be linked to relaxation in social behaviour
or similar factors – this is more like a ‘wavelet’ as discussed in the
previous presentation
19. • June target of 120 Mn doses was met. July target has been taken at the same level.
• So far July is on target
• For this year the Govt has committed to vaccinating all Indians by End Dec 2021. I have taken that to mean at least 1 jab for all adults
by year end
• There is no clarity regarding availability of Sputnik or capacity enhancement at SII or Bharat Biotech. Accelerating beyond 4 Mn
doses/day is dependent on this and/or availability of some new vaccines
India Vaccination Progress
Day Jul-21 FY 21
Target 12,00,00,000 1,35,49,50,000
Avg/Day 38,70,968 38,71,286
Achievement
01-Jul 1 43,60,213
02-Jul 2 45,35,059
03-Jul 3 66,10,015
04-Jul 4 16,70,740
05-Jul 5 46,61,566
06-Jul 6 37,69,936
07-Jul 7 35,24,001
08-Jul 8 41,43,673
09-Jul 9 32,05,046
10-Jul 10 38,36,318
11-Jul 11 13,19,915
12-Jul 12 41,45,145
Cum 4,57,81,627 38,14,97,646
Avg/Day 38,15,136 21,43,245
Bal 7,42,18,373 97,34,52,354
Bal Avg/Day 39,06,230 56,59,607
Acceleration 102.4% 264.1%
21. Waves vs Wavelets
• Speculation:
• Are wavelets of the type that Delhi
exhibited prior to the wave in
April/May 2021 the same as the
latter?
• Wavelets appear to be caused by
relaxation in Covid appropriate
behaviour such as what happened in
Delhi and North India around Diwali.
They tend to recede when behaviour
is tightened.
• Wavelets appear to be caused by the
same strain as the original. A true
wave is caused by a new strain (in
India – Delta) and in UK – Alpha
• India’s second wave has been
remarkably consistent across states
and geographies – pointing to the
relative ineffectiveness of normal
covid control measures in stopping
the wave cased by the Delta variant
22. 3rd Wave www.nature.com Multiwave pandemic dynamics explained: how to tame the next wave of infectious diseases
Giacomo Cacciapaglia 1,2,5*, Corentin Cot1,2,5 & Francesco Sannino3,4,5
• “The key to control the arrival of the next
wave of a pandemic is in the strolling
period in between waves, i.e. when the
number of infections grows linearly. Thus,
limiting the virus diffusion in this period is
the most effective way to prevent or
delay the arrival of the next wave”
• UK 3rd wave is predicted to peak on
24.07.21 with 75% cases of the 2nd wave
• Update: As on 11.07.21 UK 7DMA is
31,215. The 2nd wave peak was 59,441 on
11.01.21. 75% of that peak is 44,580
23. 3rd Wave – Manindra Agrawal
• Sutra Model
• Contact Rate – Beta. Closely related to R0. R0 = 10Beta
• Reduction Factor – Epsilon. Measures the ratio between reported and actual cases
• Reach – Rho. Measures fraction of population over which pandemic is active. Captures loss of
immunity and vaccine driven immunity
• Model is theoretically sound. However, forecasting of parameters appears to be
based on imperfect studies and many estimates. My sense is that it may work in a
fairly stable situation but may find it difficult to capture the rapid spread of a new
variant such as Delta or even overwhelming covid inappropriate behaviour
• Manindra Agarwal explains the rise in cases in Kerala saying that Epsilon is rising.
This is also captured by a high TPR. Kerala needs to test more to bring TPR down
from 10.4% to 5%. No of discovered cases will go up but not in the same
proportion. This will also help in contact tracing and isolation
24. • Manindra Agarwal
- Monster 3rd wave
unlikely
• Timing around 3rd
week of October.
However, his
assumption that
Covid appropriate
behaviour will
continue through
August is already
proving wrong
25. India 3rd Wave
• Influencing Variables
• Strolling period
• New Variant
• Speculation
• The gap between Wave 2 and 3 in UK is projected to be around 6 months. Assuming
a similar situation for India it would indicate a peak for Wave 3 around Nov 2021
• Strolling period behaviour unlikely to be Covid appropriate. Vaccination drive has
remained slow in June and probably July. This might hasten the 3rd wave
• If there is no variant we may get away with a mild wave. If there is a new variant with
significant immune escape it could be possibly worse than Wave 2
27. Thank You!
Please mail me at debubhatnagar@gmail.com
with any comments.
Disclaimer: These projections and analysis are not official and are the work of an
amateur. They should not be the basis of any decision making.